For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.

Anna Stiekema studies the role of the new biomarker Human Epididymis protein 4 in different clinical settings in gynaecological cancer. She focuses on the early detection and preoperative diagnosis of epithelial ovarian cancer and on the preoperative selection of patients with endometrial cancer.

Event details of Applications of new biomarker in gynaecological cancer
Date 9 February 2017
Time 10:00 -11:00
Location Agnietenkapel
Room Location

A. Stiekema: HE4 Clinical Applications in Gynaecological Cancer.


Prof. G.G. Kenter (UvA, Vrije Universiteit)


Dr C.A.R. Lok (CGOA – Antoni van Leeuwenhoek)

Dr C.M. Korse (Nederlands Kanker Instituut – Antoni van Leeuwenhoek)


Room Location

Oudezijds Voorburgwal 229 - 231
1012 EZ Amsterdam


This event is open to the public.